STOCK TITAN

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) announced its participation in two upcoming investor conferences. The Goldman Sachs Healthcare Conference will feature a fireside chat on June 10, 2021 at 8:00 a.m. ET, while the Bank of America Napa Biopharma Conference is set for June 16, 2021 at 4:30 p.m. ET. Both events will be available via live webcast and can be accessed from the company’s investors and media page. Replays will be accessible for 90 days post-event.

Apellis focuses on pioneering targeted C3 therapies for various diseases.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., June 03, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company will participate in the following investor conferences in June:

  • Goldman Sachs Healthcare Conference: Fireside chat on Thursday, June 10, 2021 at 8:00 a.m. ET.
  • Bank of America Napa Biopharma Conference: Fireside chat on Wednesday, June 16, 2021 at 4:30 p.m. ET.

The Conference events will be available via live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website at https://investors.apellis.com/events-and-presentations. Replays of the webcasts will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com.

Investor Contact:
Argot Partners
apellis@argotpartners.com
212.600.1902

 


FAQ

When will Apellis Pharmaceuticals participate in investor conferences?

Apellis Pharmaceuticals will participate in the Goldman Sachs Healthcare Conference on June 10, 2021, and the Bank of America Napa Biopharma Conference on June 16, 2021.

What time is the fireside chat at the Goldman Sachs Healthcare Conference?

The fireside chat at the Goldman Sachs Healthcare Conference is scheduled for 8:00 a.m. ET on June 10, 2021.

How can I access the webcasts from Apellis Pharmaceuticals' investor conferences?

The webcasts for Apellis Pharmaceuticals' investor conferences can be accessed via the 'Events and Presentations' page on their website.

How long will the webcasts from Apellis Pharmaceuticals be available for replay?

Replays of the webcasts will be available for 90 days following the events.

What is the main focus of Apellis Pharmaceuticals?

Apellis Pharmaceuticals specializes in targeted C3 therapies for a range of diseases related to excessive complement activation.

Apellis Pharmaceuticals, Inc.

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Stock Data

4.12B
105.50M
13.98%
99.97%
18.64%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WALTHAM